The liver plays a crucial role in the metabolism of asymmetric-dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase. ADMA is metabolized via dimethylarginine-dimethylaminohydrolase (DDAH). This study investigated whether changes in serum levels of ADMA occur in a rat model of non-alcoholic steatohepatitis (NASH) and what is the mechanism involved.
Changes in serum levels of asymmetric dimethylarginine (ADMA) in a rat model of nonalcoholic steatohepatitis: role of oxidative stress
CROCE AC;BOTTIROLI G;
2014
Abstract
The liver plays a crucial role in the metabolism of asymmetric-dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase. ADMA is metabolized via dimethylarginine-dimethylaminohydrolase (DDAH). This study investigated whether changes in serum levels of ADMA occur in a rat model of non-alcoholic steatohepatitis (NASH) and what is the mechanism involved.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
